Comment on

• Perspectives on oral pulmonary hypertension therapies recently approved by the U.S. Food and Drug Administration.

  Hill NS, Badesch D, Benza RL, D'Eletto TA, Farber HW, Gomberg-Maitland M, Hassoun PM, Preston I. Hill NS, et al. Ann Am Thorac Soc. 2015 Feb;12(2):269-73. doi: 10.1513/AnnalsATS.201501-020AS. Ann Am Thorac Soc. 2015. PMID: 25590376
• Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.

  Burger CD. Burger CD. Ann Am Thorac Soc. 2015 Jun;12(6):959. doi: 10.1513/AnnalsATS.201503-114LE. Ann Am Thorac Soc. 2015. PMID: 26075561 No abstract available.